Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 4/20 | 0.46 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.46 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.46 |
| ▸ | CPT2 | P23786 | 1/20 | 0.40 |
| ▸ | CPT1A | P50416 | 1/20 | 0.40 |
| ▸ | ACE | P12821 | 2/20 | 0.40 |
| ▸ | PREP | P48147 | 3/20 | 0.39 |
| ▸ | FAP | Q12884 | 1/20 | 0.39 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 2/20 | 0.37 |
| ▸ | HTR7 | P34969 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8182012 | 0.81 | ACE (0.44) | DPP4DPP8DPP7ACEPREP | |
| SCHEMBL15778534 | 0.79 | DPP4 (0.44) | DPP4DPP8DPP7CPT2CPT1A | |
| SCHEMBL11267262 | 0.73 | DPP4 (0.45) | DPP4DPP8DPP7ACE | |
| Hydrochloric Acid SCHEMBL11279921 | 0.72 | DPP4 (0.45) | DPP4DPP8DPP7ACE | |
| SCHEMBL14311868 | 0.71 | PREP (0.50) | DPP4DPP8DPP7CPT2CPT1A | |
| Hydrochloric Acid SCHEMBL10974126 | 0.71 | CPT2 (0.48) | DPP4DPP8DPP7CPT2CPT1A | |
| SCHEMBL8772871 | 0.70 | DPP4 (0.56) | DPP4DPP8ACEPREPFAP | |
| Glycyl Proline SCHEMBL155067 | 0.70 | ACE (0.62) | DPP4DPP8ACEPREPFAP | |
| Glycyl Proline SCHEMBL30051559 | 0.70 | ACE (0.62) | DPP4DPP8ACEPREPFAP | |
| SCHEMBL8772866 | 0.70 | DPP4 (0.56) | DPP4DPP8ACEPREPFAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009152186-A1 | METHODS FOR ENHANCING CELL THERAPY EFFICACY INCLUDING TREATMENT WITH CD26 PEPTIDASE INHIBITORS | AMERICAN STEM CELL, INC. (US) | 2009-12-17 | — | — | WO | disclosed |
| EP-1553937-A4 | GLYCINENITRILE-BASED INHIBITORS OF DIPEPTIDYL PEPTIDASE IV AND METHODS | BRISTOL MYERS SQUIBB CO (US) | 2006-07-19 | — | — | EP | disclosed |
| EP-1553937-A2 | GLYCINENITRILE-BASED INHIBITORS OF DIPEPTIDYL PEPTIDASE IV AND METHODS | Bristol-Myers Squibb Company (US) | 2005-07-20 | — | — | EP | disclosed |
| WO-2004037181-A2 | GLYCINENITRILE-BASED INHIBITORS OF DIPEPTIDYL PEPTIDASE IV AND METHODS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2004-05-06 | — | — | WO | disclosed |
| WO-1999047152-A2 | USE OF DIPEPTIDYL PEPTIDASE (DPP4) OF FIBROBLAST ACTIVATING PROTEIN ALPHA FOR SUPPRESSING THE MALIGNANT PHENOTYPE OF CANCER CELLS | SLOAN KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1999-09-23 | — | — | WO | disclosed |